Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans

Microvascular Research

Volumn 87, Issue , 2013, Pages 58-64

  Smith, Caroline J ^a   Santhanam, Lakshmi ^b   Alexander, Lacy M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FASUDIL; MYOSIN; MYOSIN PHOSPHATASE TARGET SUBUNIT 1; PROPRANOLOL; RHO KINASE; UNCLASSIFIED DRUG; YOHIMBINE;

ADULT; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; COOLING; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKIN BIOPSY; SKIN BLOOD FLOW; VASOCONSTRICTION; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; BIOPSY; BLOOD FLOW VELOCITY; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLD TEMPERATURE; FEMALE; HUMANS; HYPERTENSION; LASER-DOPPLER FLOWMETRY; MALE; MICRODIALYSIS; MIDDLE AGED; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; PREHYPERTENSION; PROTEIN KINASE INHIBITORS; REGIONAL BLOOD FLOW; RHO-ASSOCIATED KINASES; SKIN; TIME FACTORS; UP-REGULATION; VASOCONSTRICTION;

EID: 84876340735     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.02.005     Document Type: Article

References (45)

1. Abularrage C.J., et al. Evaluation of the microcirculation in vascular disease. J. Vasc. Surg. 2005, 42:574-581.
2. AHA Heart Disease and Stroke Statistics - 2006 Update 2006, American Heart Assocication.
3. Anggrahini D.W., et al. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. Cardiovasc. Res. 2009, 82:143-151.
4. Bailey S.R., et al. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ. Res. 2004, 94:1367-1374.
5. Chotani M.A., et al. Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1075-H1083.
6. Cohuet G., Struijker-Boudier H. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol. Ther. 2006, 111:81-98.
7. Coulon P., et al. Impairment of skin blood flow during post-occlusive reactive hyperhemy assessed by laser Doppler flowmetry correlates with renal resistive index. J. Hum. Hypertens. 2011, 26:56-63.
8. Eto M., et al. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways. Circ. Res. 2001, 89:583-590.
9. Feletou M., et al. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br. J. Pharmacol. 2009, 156:563-574.
10. Hiroki J., et al. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J. Mol. Cell. Cardiol. 2004, 37:537-546.
11. Holowatz L.A., Kenney W.L. Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans. Am. J. Physiol. Heart Circ. Physiol. 2007, 293(2):H1090-H1096.
12. Holowatz L.A., Kenney W.L. Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1090-H1096.
13. Holowatz L.A., Kenney W.L. Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans. J. Physiol. 2007, 581:863-872.
14. Holowatz L.A., et al. The human cutaneous circulation as a model of generalized microvascular function. J. Appl. Physiol. 2008, 105:370-372.
15. Hughes I.E., Smith J.A. The stability of noradrenaline in physiological saline solutions. J. Pharm. Pharmacol. 1978, 30:124-126.
16. Izzo J.L., et al. Hypertension Primer 2008, Lippincot, Williams, and Wilkins, Philadelphia, USA. Fourth edition.
17. Jablonski K.L., et al. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J. Am. Coll. Cardiol. 2012, 61(3):335-343.
18. Jeyaraj S.C., et al. Cooling evokes redistribution of alpha2C-adrenoceptors from Golgi to plasma membrane in transfected human embryonic kidney 293 cells. Mol. Pharmacol. 2001, 60:1195-1200.
19. Kim J.H., et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. 2009, 107:1249-1257.
20. Kokubo Y., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort - the Suita Study. Hypertension 2008, 52:652-659.
21. Lang J.A., et al. Reflex vasoconstriction in aged human skin increasingly relies on rho-kinase dependent mechanisms during whole-body cooling. Am. J. Physiol. Heart Circ. Physiol. 2009, 297(5):H1792-H1797.
22. Lauer T., et al. Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension. J. Hypertens. 2005, 23:563-569.
23. Levy B.I., et al. Microcirculation in hypertension: a new target for treatment?. Circulation 2001, 104:735-740.
24. Mancia G. 2007 Guidelines for the Management of Arterial Hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology (vol 25, pg 1105, 2007). J. Hypertens. 2007, 25:1749.
25. Masumoto A., et al. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001, 38:1307-1310.
26. Ming X.F., et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol. Cell. Biol. 2002, 22:8467-8477.
27. Minson C.T., et al. Decreased nitric oxide- and axon reflex-mediated cutaneous vasodilation with age during local heating. J. Appl. Physiol. 2002, 93:1644-1649.
28. Mukai Y., et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J. 2001, 15:1062-1064.
29. Oi K., et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler. Thromb. Vasc. Biol. 2004, 24:918-922.
30. Pickering T.G., et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005, 45:142-161.
31. Rizzoni D., Agabiti-Rosei E. Endothelial factors and microvascular hypertensive disease. J. Cardiovasc. Pharmacol. 2001, 38(Suppl. 2):S15-S18.
32. Rizzoni D., et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003, 108:2230-2235.
33. Rossi M., et al. The investigation of skin blood flowmotion: a new approach to study the microcirculatory impairment in vascular diseases?. Biomed. Pharmacother. 2006, 60:437-442.
34. Seko T., et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ. Res. 2003, 92:411-418.
35. Serne E.H., et al. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001, 38:238-242.
36. Smith C.J., et al. Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension 2011, 58:935-942.
37. Stewart J., et al. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2687-H2696.
38. Takemoto M., et al. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 2002, 106:57-62.
39. Tang E.H., Vanhoutte P.M. Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol. Genomics 2008, 32:409-418.
40. Thompson C.S., Kenney W.L. Altered neurotransmitter control of reflex vasoconstriction in aged human skin. J. Physiol. 2004, 558:697-704.
41. Thompson C.S., et al. Cutaneous vasoconstrictor responses to norepinephrine are attenuated in older humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R1108-R1113.
42. Thompson-Torgerson C.S., et al. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1700-H1705.
43. Thompson-Torgerson C.S., et al. Rho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:30-36.
44. Uehata M., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
45. Vasan R.S., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N. Engl. J. Med. 2001, 345:1291-1297.